Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • State of the Art
  • Published:

Extended Spectrum β Lactamase-producing Klebsiella pneumoniae Infections: a Review of the Literature

Journal of Perinatology volume 23, pages 439–443 (2003)Cite this article

Abstract

Infections caused by extended-spectrum β-lactamase (ESBL)-producing pathogens, particularly Klebsiella pneumoniae, are increasing. The epidemiology of ESBL-producing K. pneumoniae, the mechanisms of resistance, and treatment strategies for infections caused by these organisms are reviewed.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Itokazu G, Quinn J, Bell-Dixon C, Kahan F, Weinstein R . Antimicrobial resistance rates among aerobic Gram-negative bacilli recovered from patients in intensive care units: Evaluation of a national postmarketing surveillance program . Clin Infect Dis 1996;23:779–784.

    CAS  PubMed  Google Scholar 

  2. Burwen DR, Banerjee SN, Gaynes RP . Ceftazidime resistance among selected nosocomial Gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System. J Infect Dis 1994;170:1622–1625.

    Article  CAS  Google Scholar 

  3. Karas JA, Pillay DG, Muckart D, Sturm AW . Treatment failure due to extended spectrum β-lactamase. J Antimicrob Chemother 1996;37:203–204.

    Article  CAS  Google Scholar 

  4. Podschun R, Ullmann U . Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998;11:589–603.

    Article  CAS  Google Scholar 

  5. Morgan ME, Hart CA, Cooke RW . Klebsiella infection in a neonatal intensive care unit: role of bacteriological surveillance. J Hosp Infect 1984;5:377–385.

    Article  CAS  Google Scholar 

  6. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S . Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983;11:315–317.

    Article  CAS  Google Scholar 

  7. Quinn JP, Miyashiro D, Sahm D, Flamm R, Bush K . Novel plasmid-mediated β-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1989;33:1451–1456.

    Article  CAS  Google Scholar 

  8. Quale JM, Landman D, Bradford PA, et al. Molecular epidemiology of a citywide outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae infection. Clin Infect Dis 2002;35:834–841.

    Article  CAS  Google Scholar 

  9. Athamna A, Ofek I, Keisari Y, et al. Lectinophagocytosis of encapsulated Klebsiella pneumoniae mediated by surface lectins of guinea pig alveolar macrophages and human monocyte-derived macrophages. Infect Immun 1991;59:1673–1682.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Griffiths E, Chart H, Stevenson P . High affinity iron uptake systems and bacterial virulence. In: Roth JA, editor. Virulence Mechanics of Bacterial Pathogens. Washington, DC: American Society for Microbiology; 1988.p. 121–137.

    Google Scholar 

  11. Nathisuwan S, Burgess DS, Lewis JS . Extended-spectrum β-lactamases: epidemiology, detection, and treatment. Pharmacotherapy 2001;21:920–928.

    Article  CAS  Google Scholar 

  12. Jacoby GA, Sutton L . Properties of plasmids responsible for production of extended-spectrum β-lactamases. Antimicrob Agents Chemother 1991;35:164–169.

    Article  CAS  Google Scholar 

  13. Sirot D, De-Champs C, Chanal C, et al. Translocation of antibiotic resistance determinants including an extended-spectrum β-lactamase between conjugative plasmids of Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 1991;35:1576–1581.

    Article  CAS  Google Scholar 

  14. Venezia RA, Scarano FJ, Preston KE, et al. Molecular epidemiology of an SHV-5 extended-spectrum β-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit. Clin Infect Dis 1995;21:915–923.

    Article  CAS  Google Scholar 

  15. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5. ed. Wayne, PA: NCCLS, 2000.

  16. National Committee for Clinical Laboratory Standards. Approved standard M-100-S10: performance standards for antimicrobial susceptibility testing. ed. Wayne, PA: NCCLS, 2000.

  17. Sirot D . Extended-spectrum plasmid-mediated β-lactamases. J Antimicrob Chemother 1995;36 (Suppl A): 19–34.

    Article  CAS  Google Scholar 

  18. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ . Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353–358.

    Article  CAS  Google Scholar 

  19. Naumovski L, Quinn JP, Miyashiro D, et al. Outbreak of ceftazidime resistance due to a novel extended-spectrum β-lactamase in isolates from cancer patients. Antimicrob Agents Chemother 1992;36:1991–1996.

    Article  CAS  Google Scholar 

  20. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO . Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis 2001;32:1162–1171.

    Article  CAS  Google Scholar 

  21. Jacoby GA . Extended-spectrum β-lactamases and other enzymes providing resistance to oxyimino-β-lactams. Infect Dis Clin North Am 1997;11:875–887.

    Article  CAS  Google Scholar 

  22. Jacoby GA . Editorial response: epidemiology of extended-spectrum β-lactamases. Clin Infect Dis 1998;27:81–83.

    Article  CAS  Google Scholar 

  23. Gaillot O, Maruejouls C, Abachin E, et al. Nosocomial outbreak of Klebsiella pneumoniae producing SHV-5 extended-spectrum β-lactamase, originating from a contaminated ultrasonography coupling gel. J Clin Microbiol 1998;36:1357–1360.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. French GL, Shannon KP, Simmons N . Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam-β-lactamase inhibitor combinations by hyperproduction of SHV-5 β-lactamase. J Clin Microbiol 1996;34:358–363.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Casewell MW, Phillips I . Aspects of the plasmid-mediated antibiotic resistance and epidemiology of Klebsiella species. Am J Med 1981;70:459–462.

    Article  CAS  Google Scholar 

  26. Gupta A, San Gabriel P, Haas J, et al. Extended spectrum ß-lactamase (ESBL) producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit (NICU). Abstract 241. In: 12th Annual Scientific Meeting of Society for Healthcare Epidemiology of America (SHEA), Salt Lake City, UT, April, 2002. SHEA, 2002 (published).

  27. Hart CA . Klebsiellae and neonates. J Hosp Infect 1993;23:83–86.

    Article  CAS  Google Scholar 

  28. Stoll BJ, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996;129:63–71.

    Article  CAS  Google Scholar 

  29. Sohn AH, Garrett DO, Sinkowitz-Cochran RL, et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr 2001;139:821–827.

    Article  CAS  Google Scholar 

  30. Gaynes RP, Edwards JR, Jarvis WR, et al. Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics 1996;98:357–361.

    CAS  Google Scholar 

  31. Rice LB, Willey SH, Papanicolaou GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum β-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990;34:2193–2199.

    Article  CAS  Google Scholar 

  32. Paterson DL, Ko WC, Von-Gottberg A, et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum β-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001;39:2206–2212.

    Article  CAS  Google Scholar 

  33. Emery CL, Weymouth LA . Detection and clinical significance of extended-spectrum β-lactamases in a tertiary-care medical center. J Clin Microbiol 1997;35:2061–2067.

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Jacoby GA, Carreras I . Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1990;34:858–862.

    Article  CAS  Google Scholar 

  35. Payne DJ, Cramp R, Winstanley DJ, Knowles DJ . Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important β-lactamases. Antimicrob Agents Chemother 1994;38:767–772.

    Article  CAS  Google Scholar 

  36. Sanders WE, Sanders CC . Piperacillin/tazobactam: a critical review of the evolving clinical literature. Clin Infect Dis 1996;22:107–123.

    Article  CAS  Google Scholar 

  37. Pillay T, Pillay DG, Adhikari M, Sturm AW . Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates. Am J Perinatol 1998;15:47–51.

    Article  CAS  Google Scholar 

  38. Mentec H, Vallois JM, Bure A, et al. Piperacillin, tazobactam, and gentamicin alone or combined in an endocarditis model of infection by a TEM-3-producing strain of Klebsiella pneumoniae or its susceptible variant. Antimicrob Agents Chemother 1992;36:1883–1889.

    Article  CAS  Google Scholar 

  39. Leleu G, Kitzis MD, Vallois JM, Gutmann L, Decazes JM . Different ratios of the piperacillin–tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum β-lactamase. Antimicrob Agents Chemother 1994;38:195–199.

    Article  CAS  Google Scholar 

  40. Piroth L, Aube H, Doise JM, Vincent-Martin M . Spread of extended-spectrum β-lactamase-producing Klebsiella pneumoniae: are β-lactamase inhibitors of therapeutic value? Clin Infect Dis 1998;27:76–80.

    Article  CAS  Google Scholar 

  41. Schiappa DA, Hayden MK, Matushek MG, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case–control and molecular epidemiologic investigation. J Infect Dis 1996;174:529–536.

    Article  CAS  Google Scholar 

  42. Szabo D, Mathe A, Lengyel J, et al. In vitro and in vivo activities of ciprofloxacin and levofloxacin against an SHV-5 extended-spectrum β-lactamase-producing Klebsiella pneumoniae strain. Curr Med Chem 2002;9:437–442.

    Article  CAS  Google Scholar 

  43. Paterson DL, Mulazimoglu L, Casellas JM, et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum β-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis 2000;30:473–478.

    Article  CAS  Google Scholar 

  44. Takizawa T, Hashimoto K, Minami T, Yamashita S, Owen K . The comparative arthropathy of fluoroquinolones in dogs. Hum Exp Toxicol 1999;18:392–399.

    Article  CAS  Google Scholar 

  45. Boyce JM, Pittet D, HICPAC, et al. Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR Recomm Rep 2002;51:1–45, quiz CE1-4.

    PubMed  Google Scholar 

  46. Coovadia YM, Johnson AP, Bhana RH, et al. Multiresistant Klebsiella pneumoniae in a neonatal nursery: the importance of maintenance of infection control policies and procedures in the prevention of outbreaks. J Hosp Infect 1992;22:197–205.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neonatology, Division of Infectious Diseases, Department of Pediatrics, The Children's Hospital of New York, New York Presbyterian Medical Center, NY, USA

    Archana Gupta MD, David Rubenstein MD & Lisa Saiman MD, MPH

  2. Department of Epidemiology, New York Presbyterian Medical Center, New York, NY, USA

    Lisa Saiman MD, MPH

  3. Division of Pediatric Infectious Diseases, University of Utah School of Medicine, Salt Lake City, UT, USA

    Krow Ampofo MD

Authors
  1. Archana Gupta MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Krow Ampofo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David Rubenstein MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lisa Saiman MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gupta, A., Ampofo, K., Rubenstein, D. et al. Extended Spectrum β Lactamase-producing Klebsiella pneumoniae Infections: a Review of the Literature. J Perinatol 23, 439–443 (2003). https://doi.org/10.1038/sj.jp.7210973

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7210973

This article is cited by

Search

Advanced search

Quick links